Almasilate (CED0022033)

Record Information
Version1.0
Creation Date2026-04-14 19:28:14 UTC
Update Date2026-05-14 19:35:04 UTC
SynCED IDCED0022033
Secondary Accession Numbers
  • CHEM131939
Identification
Common NameAlmasilate
ClassSmall Molecule
Description
Almasilate is an inorganic compound with the formula Al2H2MgO9Si2 and an average molecular weight of 280.44 g/mol. Almasilate belongs to the post-transition metal silicates, a subclass of post-transition metal oxoanionic compounds within the inorganic compounds. It is classified as a mixed metal/non-metal compound. This substance is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically drugs for acid related disorders. The recorded route of exposure for this compound is oral.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaAl2H2MgO9Si2
Average Molecular Mass280.445 g/mol
Monoisotopic Mass279.872 g/mol
CAS Registry Number71205-22-6
IUPAC NameNot Available
Traditional NameNot Available
SMILESO.[Mg++].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-]
InChI IdentifierInChI=1S/2Al.Mg.2O4Si.H2O/c;;;2*1-5(2,3)4;/h;;;;;1H2/q2*+3;+2;2*-4;
InChI KeyXFKLULFTFNRQOX-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity ValuesNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000242Drugs for acid related disorders?Drugs for acid-related disorders primarily include proton pump inhibitors (PPIs), H2 receptor antagonists, and antacids, which are used to manage conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Carbonic anhydrase 1 structureClick to view 3D structureCarbonic anhydrase 1P00915HumansPredicted (SEA)
Prediction Confidence Score
0.081
Applicability Domain
0.095 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
407
E-value
7784.77
Carbonic anhydrase 4 structureClick to view 3D structureCarbonic anhydrase 4P22748HumansPredicted (SEA)
Prediction Confidence Score
0.073
Applicability Domain
0.095 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
193
E-value
7784.46
Carbonic anhydrase 2 structureClick to view 3D structureCarbonic anhydrase 2P00918HumansPredicted (SEA)
Prediction Confidence Score
0.073
Applicability Domain
0.077 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
472
E-value
7784.77
Carbonic anhydrase 9 structureClick to view 3D structureCarbonic anhydrase 9Q16790HumansPredicted (SEA)
Prediction Confidence Score
0.07
Applicability Domain
0.077 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
372
E-value
7784.84
Click to view 3D structureNitric oxide synthase 3P70313Mus musculusPredicted (SEA)
Prediction Confidence Score
0.07
Applicability Domain
0.07 Low confidence
Statistical Significance
0.9387
Supporting Reference Compounds
1
E-value
7307.63
Aromatase structureClick to view 3D structureAromataseP11511HumansPredicted (SEA)
Prediction Confidence Score
0.067
Applicability Domain
0.075 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
127
E-value
7784.22
Procathepsin L structureClick to view 3D structureProcathepsin LP07711HumansPredicted (SEA)
Prediction Confidence Score
0.065
Applicability Domain
0.076 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
167
E-value
7784.53
Carbonic anhydrase 7 structureClick to view 3D structureCarbonic anhydrase 7P43166HumansPredicted (SEA)
Prediction Confidence Score
0.064
Applicability Domain
0.075 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
242
E-value
7784.53
Prostaglandin G/H synthase 2 structureClick to view 3D structureProstaglandin G/H synthase 2P35354HumansPredicted (SEA)
Prediction Confidence Score
0.063
Applicability Domain
0.075 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
201
E-value
7784.61
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)
Prediction Confidence Score
0.063
Applicability Domain
0.076 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
1538
E-value
7784.69
Protein deacetylase HDAC6 structureClick to view 3D structureProtein deacetylase HDAC6Q9UBN7HumansPredicted (SEA)
Prediction Confidence Score
0.062
Applicability Domain
0.071 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
553
E-value
7784.53
Cathepsin K structureClick to view 3D structureCathepsin KP43235HumansPredicted (SEA)
Prediction Confidence Score
0.062
Applicability Domain
0.076 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
129
E-value
7784.53
Protein RecA structureClick to view 3D structureProtein RecAP9WHJ3Mycobacterium tuberculosisPredicted (SEA)
Prediction Confidence Score
0.061
Applicability Domain
0.075 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
296
E-value
7784.53
Thioredoxin reductase structureClick to view 3D structureThioredoxin reductaseP61076Plasmodium falciparum 3D7Predicted (SEA)
Prediction Confidence Score
0.061
Applicability Domain
0.061 Low confidence
Statistical Significance
0.5011
Supporting Reference Compounds
1
E-value
3900.95
Cathepsin B structureClick to view 3D structureCathepsin BP07858HumansPredicted (SEA)
Prediction Confidence Score
0.06
Applicability Domain
0.076 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
173
E-value
7784.61
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)
Prediction Confidence Score
0.06
Applicability Domain
0.076 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
1245
E-value
7784.69
Cytochrome P450 11B1, mitochondrial structureClick to view 3D structureCytochrome P450 11B1, mitochondrialP15538HumansPredicted (SEA)
Prediction Confidence Score
0.06
Applicability Domain
0.075 Low confidence
Statistical Significance
0.9998
Supporting Reference Compounds
66
E-value
7783.29
Cytochrome P450 11B2, mitochondrial structureClick to view 3D structureCytochrome P450 11B2, mitochondrialP19099HumansPredicted (SEA)
Prediction Confidence Score
0.06
Applicability Domain
0.075 Low confidence
Statistical Significance
0.9998
Supporting Reference Compounds
62
E-value
7783.13
DNA-3-methyladenine glycosylase 1 structureClick to view 3D structureDNA-3-methyladenine glycosylase 1P05100Escherichia coli (strain K12)Predicted (SEA)
Prediction Confidence Score
0.059
Applicability Domain
0.059 Low confidence
Statistical Significance
0.8299
Supporting Reference Compounds
1
E-value
6460.4
Mitogen-activated protein kinase 14 structureClick to view 3D structureMitogen-activated protein kinase 14Q16539HumansPredicted (SEA)
Prediction Confidence Score
0.059
Applicability Domain
0.074 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
668
E-value
7784.69
Histone deacetylase 8 structureClick to view 3D structureHistone deacetylase 8Q9BY41HumansPredicted (SEA)
Prediction Confidence Score
0.059
Applicability Domain
0.071 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
317
E-value
7784.53
Replicase polyprotein 1ab structureClick to view 3D structureReplicase polyprotein 1abP0DTD1SARS-CoV-2Predicted (SEA)
Prediction Confidence Score
0.059
Applicability Domain
0.077 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
215
E-value
7784.69
Histone deacetylase 7 structureClick to view 3D structureHistone deacetylase 7Q8WUI4HumansPredicted (SEA)
Prediction Confidence Score
0.058
Applicability Domain
0.071 Low confidence
Statistical Significance
0.9999
Supporting Reference Compounds
148
E-value
7784.46
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.058
Applicability Domain
0.063 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
953
E-value
7784.61
Carbonic anhydrase 12 structureClick to view 3D structureCarbonic anhydrase 12O43570HumansPredicted (SEA)
Prediction Confidence Score
0.058
Applicability Domain
0.07 Low confidence
Statistical Significance
1.0
Supporting Reference Compounds
332
E-value
7784.69
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available